Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FARMINGTON HILLS, Mich., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. OCUP, a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced that the…#farmingtonhills #mich #ocuphirepharmainc #boardofdirectors #ashwathjayagopal #phd #niravjhaveri #cfa #nasdaqlistingrule #ocuphire (Source: Reuters: Health)
Source: Reuters: Health - February 15, 2024 Category: Consumer Health News Source Type: news
When Clock's Ticking on Vision Loss, New Protocol Speeds Eye Stroke Diagnoses
(MedPage Today) -- A remote consult protocol using point-of-care automated optical coherence tomography (OCT) for the rapid treatment of retinal artery occlusions proved successful in a small group of patients, according to a retrospective case... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - February 14, 2024 Category: Radiology Source Type: news
Machine Learning Can Predict Eyes at Risk for Diabetic Retinopathy Progression
TUESDAY, Feb. 13, 2024 -- Automated machine learning models may help identify eyes at risk for diabetic retinopathy (DR) progression based on ultra-widefield retinal images, according to a study published online Feb. 8 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 13, 2024 Category: Pharmaceuticals Source Type: news
Retinol, acids and serums for kids? A dermatologist ’s guide to age appropriate skincare
Last month the British Association of Dermatologists warned that children as young as eight years old were using potentially damaging anti-ageing skin care products. Madeleine Finlay speaks to consultant dermatologist Dr Emma Wedgeworth about where this trend has come from, what damage these products might be causing to young skin and how we can all look after our skin without spending too much time and moneyContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 13, 2024 Category: Science Authors: Presented and produced by Madeleine Finlay, sound design by Tony Onuchukwu, the executive producer is Ellie Bury Tags: Science Skincare Beauty Life and style Fashion Society Children Social media TikTok Technology Digital media Source Type: news
Retinol, acids and serums for kids? A dermatologist ’s guide to age appropriate skincare – podcast
Last month the British Association of Dermatologists warned that children as young as eight years old were using potentially damaging anti-ageing skin care products. Madeleine Finlay speaks to consultant dermatologist Dr Emma Wedgeworth about where this trend has come from, what damage these products might be causing to young skin and how we can all look after our skin without spending too much time and moneyContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 13, 2024 Category: Science Authors: Presented and produced by Madeleine Finlay, sound design by Tony Onuchukwu, the executive producer is Ellie Bury Tags: Science Skincare Beauty Life and style Fashion Society Children Social media TikTok Technology Digital media Source Type: news
New long-term data for Roche ’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry visionUp to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months apartDetailed results from two global Phase III RVO studies will be presented at Angiogenesis, Exudation, and Degeneration 2024Vabysmo is approved in the US for RVO, and in more than 90 countries around the world for people living with nAMD and DMEBasel, 1 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new 72-week data from two global Phase III studies, BALATON and COMINO, evaluating Vabysmo® (faricimab) i...
Source: Roche Investor Update - February 1, 2024 Category: Pharmaceuticals Source Type: news
New long-term data for Roche ’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry visionUp to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months apartDetailed results from two global Phase III RVO studies will be presented at Angiogenesis, Exudation, and Degeneration 2024Vabysmo is approved in the US for RVO, and in more than 90 countries around the world for people living with nAMD and DMEBasel, 1 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new 72-week data from two global Phase III studies, BALATON and COMINO, evaluating Vabysmo® (faricimab) i...
Source: Roche Media News - February 1, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline
Group salesgrow by 1%1 at constant exchange rates (CER; -7% in CHF), more than offsetting the decline in COVID-19-related sales and biosimilar erosion, and thereby exceeding 2023 guidanceExcluding COVID-19 products,Group sales increase by 8%Pharmaceuticals Divisionsalesincrease by 6% (excluding COVID-19 medicine Ronapreve: +9%) due to ongoing high demand for newer medicines, with eye medicine Vabysmo continuing to be the top growth driver, followed by Ocrevus (multiple sclerosis), Hemlibra (haemophilia A) and Polivy (blood cancer)Diagnostics Division salesare 13% lower due to high demand for COVID-19 tests in 2022; strong ...
Source: Roche Media News - February 1, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline
Group salesgrow by 1%1 at constant exchange rates (CER; -7% in CHF), more than offsetting the decline in COVID-19-related sales and biosimilar erosion, and thereby exceeding 2023 guidanceExcluding COVID-19 products,Group sales increase by 8%Pharmaceuticals Divisionsalesincrease by 6% (excluding COVID-19 medicine Ronapreve: +9%) due to ongoing high demand for newer medicines, with eye medicine Vabysmo continuing to be the top growth driver, followed by Ocrevus (multiple sclerosis), Hemlibra (haemophilia A) and Polivy (blood cancer)Diagnostics Division salesare 13% lower due to high demand for COVID-19 tests in 2022; strong ...
Source: Roche Investor Update - February 1, 2024 Category: Pharmaceuticals Source Type: news
Dermatologist reveals the exact time of the day to use Retinol - and how the incorrect application can AGE your skin
Dr Manuela Marcheggiani, a dermatologist in Toronto, took to TikTok to warn viewers of the common mistakes people make on their retinol skin journey, which leave them looking sore, red & older. (Source: the Mail online | Health)
Source: the Mail online | Health - January 29, 2024 Category: Consumer Health News Source Type: news
Inherited Genetic Loci Identified for Thinner Retinal Layers Using Optical CT
MONDAY, Jan. 29, 2024 -- Multiple inherited genetic loci for thinner retinal layers have been identified using macular optical computed tomography (OCT), and these are associated with ocular, neuropsychiatric, cardiometabolic, and pulmonary... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2024 Category: Pharmaceuticals Source Type: news
Can the Eye Reveal Cardiac and Lung Disease -- Plus Much More?
(MedPage Today) -- Thinner retinal layers were associated with a long list of major diseases, including pulmonary and cardiac disorders, according to a phenotypic and genomic analysis.
Among the many diseases, each standard deviation of thinner... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 26, 2024 Category: Cardiology Source Type: news
A Promising New Approach For Glaucoma
Recent medical breakthroughs in RGC (retinal ganglion cell) replacement therapy offer hope for those suffering from glaucoma. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 18, 2024 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Retinal Tumor Risk Incidentally Detected at 29 Weeks' Gestation
(MedPage Today) -- Finding poses clinical and ethical dilemma for parents and clinicians (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 9, 2024 Category: Hematology Source Type: news
Retinal hemorrhage variation in inertial versus contact head injuries - Sokoloff M, Feldman KW, Levin AV, Rockter A, Armijo-Garcia V, Musick M, Weeks K, Haney SB, Marinello M, Herman BE, Frazier TN, Carroll CL, Hymel KP.
BACKGROUND: Abusive head trauma (AHT) is frequently accompanied by dense/extensive retinal hemorrhages to the periphery with or without retinoschisis (complex retinal hemorrhages, cRH). cRH are uncommon without AHT or major trauma. OBJECTIVE: The s... (Source: SafetyLit)
Source: SafetyLit - December 25, 2023 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
